DSS, Inc.'s Form 4 filing
Impact Biomedical Inc. (IBO) · filed Nov 22, 2024
- Accession no.
- 0001493152-24-047410
- Filed
- Nov 22, 2024
- Trade date
- Nov 12-18, 2024
- Filing delay
- 10 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $17.0K. It was filed 10 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| DSS, Inc.CIK 0000771999 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2024 | Common Stock | SSaleDisposed | −500 | $2.76 | −$1,380 | 58,300 | Indirect | |
| Nov 13, 2024 | Common Stock | SSaleDisposed | −200 | $2.80 | −$560 | 58,100 | Indirect | |
| Nov 18, 2024 | Common Stock | SSaleDisposed | −5,000 | $3.02 | −$15,100 | 53,100 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.